Intersect ENT (XENT) Tops Q3 EPS by 3c

Intersect ENT (NASDAQ: XENT) reported Q3 EPS of ($0.32), $0.03 better than the analyst estimate of ($0.35). Revenue for the quarter came in at $9.1 million versus the consensus estimate of $8.2 million.

For earnings history and earnings-related data on Intersect ENT (XENT) click here.

You May Also Be Interested In

• SanDisk upgraded at JPMorgan after investor day; shares climb
• Bernstein SocGen Group Reiterates Outperform Rating on JD.com, Inc (JD), 'very cheaply valued'
• Star Equity Holdings (STRR) Misses Q2 EPS by 8c